je.st
news
Valeant Pharmaceuticals posts second-quarter loss, sales up from year ago
2015-07-23 15:18:16| Biotech - Topix.net
Valeant Pharmaceuticals International Inc. raised its financial outlook for the year as it reported a loss in its latest quarter. The drug company says it now expects revenue this year to total between $10.7 billion to $11.1 billion, up from its earlier guidance for between $10.4 billion and $10.6 billion.
Tags: year
sales
ago
posts
Category:Biotechnology and Pharmaceuticals